Unity Biotechnology Upgraded - Analyst Highlights Cash Stren

Unity Biotechnology Upgraded - Analyst Highlights Cash Strength & Execution - Unity Biotechnology (NASDAQ:UBX)

Wedbush analyst Andreas Argyrides upgraded the shares of Unity Biotechnology Inc (NASDAQ: UBX) from Neutral to Outperform and

Related Keywords

Andreas Argyrides , Unity Biotechnology Inc ,